Atlas Trials

Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Renal Function

Clinical trial NCT06106126 · UNKNOWN

Trial details

NCT number
NCT06106126
Sponsor
Fujian Akeylink Biotechnology Co., Ltd.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19 Pneumonia
Start date
2023-02-10
Primary completion
2024-02-28
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.